Skip to main content
. 2016 Jul 20;12(3):2028–2032. doi: 10.3892/ol.2016.4891

Figure 2.

Figure 2.

Expression level of phosphoproteins in the clinical specimens of invasive breast cancers, prior to (in blue) and subsequent to (in red) treatment with trastuzumab. Histogram shows the mean ± standard deviation (error bars) of phosphoprotein expression. p-, phosphorylated; AKT, protein kinase B; ERK1/2, extracellular signal regulated kinase 1/2; P70S6K, ribosomal protein S6 kinase B1; MEK, mitogen-activated protein kinase kinase 1.